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mouse model of human tauopathy (taup301l)
reveals reduced neural activity in memory
formation structures
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and Naruhiko Sahara2*Abstract
Background: Tauopathies are characterized by intracellular deposition of the microtubule-associated protein tau as
filamentous aggregates. The rTg4510 mouse conditionally expresses mutant human tau protein in various forebrain
areas under the Tet-off expression system. Mice develop neurofibrillary tangles, with significant neuronal loss and
cognitive deficits by 6 months of age. Previous behavioral and biochemical work has linked the expression and
aggregates of mutant tau to functional impairments. The present work used manganese-enhanced magnetic
resonance imaging (MEMRI) to investigate basal levels of brain activity in the rTg4510 and control mice.
Results: Our results show an unmistakable curtailment of neural activity in the amygdala and hippocampus, two
regions known for their role in memory formation, but not the cortex, cerebellum, striatum and hypothalamus in
tau expressing mice.
Conclusion: Behavioral impairments associated with changes in activity in these areas may correspond to age
progressive mutant tauP301L-induced neurodegeneration.
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Accumulation of intracellular neurofibrillary tangles (NFTs)
consisting of microtubule-associated protein tau is a major
hallmark of Alzheimer’s disease (AD) and related neurode-
generative diseases regarded as ‘tauopathies’ [1-3]. Findings
of tau mutations in subjects affected by frontotemporal de-
mentia and mutant tau expression systems, which lead to
tau-positive inclusions, neuron loss and behavioral abnor-
malities in various animal models, have established a role
of this protein in neurodegeneration [4-11].
The rTg4510 mouse line was specifically developed to
model aspects of human tauopathy, with overexpression of
human tau containing the P301L mutation that is asso-
ciated with frontotemporal dementia with parkinsonism* Correspondence: febo@ufl.edu; nsahara@ufl.edu
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reproduction in any medium, provided the orlinked to chromosome 17 (FTDP-17-Tau). Expression
of human tau in the rTg4510 mouse is controlled by
the tetracycline transactivator (tTA) transgene under the
Ca2+/calmodulin-dependent protein kinase IIα (CaMKIIα)
promoter. This leads to selective tau expression from an
otherwise transcriptionally inactive tau transgene [12].
Mice develop robust intracellular deposition of tau protein
in cortico-limbic areas, which is physiologically relevant to
AD and other tauopathies, and they also show age-related
forebrain atrophy.
The main pathological features of rTg4510 mice have
been obtained as a result of postmortem analysis of brain
tissue, except recent work employing multiphoton micro-
scopical analysis [13,14]. The advent of rodent magnetic
resonance imaging methods can fill the need for investi-
gating in vivo correlates of early signs of disease. Recent
developments in the animal imaging have led to the use of
the manganese ion (Mn2+) as a neuronal contrast agenttd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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good spatial resolution [15,16]. MEMRI thus provides a
noninvasive approach for mapping neural activity in trans-
genic mice. Mn2+ is highly paramagnetic and enhances
signal intensity in T1 weighted brain images [17,18]. It
enters neurons largely through voltage dependent calcium
channels, and possibly also via vesicular reuptake mechan-
isms, which correlates well with changes in synaptic firing
of neuronal populations [19-21]. Other MEMRI studies in
rodents have shown Mn2+ signal intensity in various ROI,
including the hippocampus, under basal conditions [17,18].
Here, we performed in vivo brain MEMRI of rTg4510 mice
and non-transgenic (nonTg) littermates. Mutant rTg4510
mice sustain significant tau-associated hippocampal atrophy
at 6 months of age and above and this was anticipated to
result in less Mn2+ signal within this region in basal un-
stimulated conditions. We observed clear differences in
basal neural activity between mutant tau expressing mice
and controls, with the magnitude of activity being lower in
rTg4510 mice. Our study extends previous applications of
MEMRI in the study of axonal transport rates in transgenic
mice by showing reduced neural activity in two structures
involved in learning and memory [22-24].
Results
Methodological considerations
We closely analyzed the intensity histograms of rTg4510
and control mice (histograms in Figure 1B). The probabil-
ity of finding voxels with a Z score of 1 or more was less
than 5% (p < 0.05; Figure 1B bottom graph inset). This
corresponds to 7.9% of the total population of brain voxels
for rTg4510 mice and 10.6% for nonTg mice (unpaired t-
test t8=3.4 p = 0.01). About 0.05% of voxels had values of
Z = −1 or less (p < 0.0003); thus, negative Z values were
negligible and not of interest in the present analysis. Only
voxels with positive Z values were considered in subse-
quent ROI analyses. We also carried out a series of pilot
experiments to determine the optimal dose of Mn2+.
Comparison of the two doses, shown in Figure 1C, high-
lights a dose-dependent effect on signal intensity. Control
nonTg mice (n = 6) administered 20 mg/kg Mn2+ showed
signal increases of significantly smaller magnitudes than a
separate cohort of nonTg mice (n = 5) administered
70 mg/kg (t-test t9=4.757 p = 0.001). The higher dose
is just below previous doses reported in the literature
for mouse (88 mg/kg in [18]), however, in our hands
70 mg/kg did not result in any overt motor or other visible
disturbances in nonTg and rTg4510 mice.
ROI analysis
High signal intensity levels were observed in subregions
of the hippocampus, hypothalamic areas, central amyg-
dala, lateral habenula, basal forebrain area, layers of the
olfactory bulb, and cerebellum, as previously reportedfor systemically administered Mn2+ [18]. We noted also
that there was high Mn2+ associated signal in the amyg-
dala, mostly pronounced in the central amygdala area.
Further qualitative inspection of each of the MRI scans
indicated a smaller hippocampal volume in rTg4510 mice
than control mice (Figure 2A T2 weighted images), con-
sistent with previous imaging of rTg4510 mice [25]. Nor-
malized voxel intensity values (in Z scores), and the
number of voxels with an intensity value equal to or above
the threshold value (mean signal and activated volume, re-
spectively) were extracted from each ROI. Signal intensity
increases were more pronounced in dorsal areas of the
hippocampus, particularly the dentate gyrus (Figure 2B).
However, increased signal intensity was still observed in
ventral CA3 (Figure 2B). Signal intensity was noticeably
lower in the hippocampus of rTg4510 mice than in con-
trols (Figure 2B). Generalized signal intensity differences
between groups did not explain this difference, as these
were normalized and values rescaled to within a similar
range (Figure 1). In addition, cortical volume, which is re-
portedly reduced in 5-month old rTg4510 mice [25], did
not show similar reductions in neural activity (Figure 3).
Thus, the reduced signal intensity is selective for hippo-
campus and amygdala, of rTg4510 mice. Significant reduc-
tions in signal intensity were observed in amygdala (t8=5.0
p = 0.001) and hippocampus (t8=3.407, p = 0.009) of
rTg4510 mice (Figure 3A). We also analyzed the number
of voxels exceeding a threshold Z score value of 1 (pre-
sumed “active regions” during basal conditions) (Figure 3B).
As stated in the methods section, we normalized the images
and set a threshold at 1 standard deviation above the mean.
Thus, all voxels below this threshold were set to zero and
signal intensities above the threshold were compared. The
active volume was lower in rTg4510 mice than in control
nonTg mice in amygdala (t8=3.7, p = 0.006) and thalamus
(t8=2.5, p = 0.04). The hippocampus showed the same trend
as with signal intensity (t8=2.0, p = 0.07). Interestingly, the
striatum showed a greater active volume in rTg4510 mice
than controls (t8=2.2, p = 0.05). Mean intensity projection
images in Figure 3C illustrate the main findings. Hippocam-
pal and amygdala signal intensity is lower in rTg4510 mice
than controls. The striatum shows the opposite effect with
greater active volume in rTg4510 mice.
Given the expression levels of human mutant tau in
the hippocampal formation of this mouse model, we
further analyzed this region for sub region specific sig-
nal intensity and volumetric differences (Figure 4A). As
indicated above, anatomical differences were clearly
discerned in scanned images of rTg4510 and nonTg
mice (Figure 2A). Surprisingly, it was noted that differ-
ences in signal intensity in the hippocampus was not
uniformly reduced throughout in rTg4510 mice. There
was a greater signal intensity in the hippocampal dorsal
CA1 region in rTg4510 mice (Figure 4B), which greatly
Figure 1 Summary of manganese (Mn2+) enhanced MRI (MEMRI) preprocessing and analysis procedure. A) Steps in image processing
and generation of Z score maps. B) Intensity histograms for raw data (top panel) and data presented as normalized z scores (bottom panel). A
comparison is made between control nonTg mice (n = 5; dark line) and rTg4510 mice (n = 5; grey lines). Data presented as mean voxel counts
(± standard error). Voxel-wise Z score calculation equation used is shown. Inset in bottom graph highlights upper portion of the histogram
accounting for voxels with increased signal intensity (Z ≥ 1). C) Effect of Mn2+ dose on mouse brain signal intensity in control scans normalized
using the Z score procedure. Data presented as mean number of voxels at Z scores equal or above 1 (n=6 for 20 mg/kg MnCl2 administration,
n=5 for 70 mg/kg MnCl2 administration, respectively). Coronal brain maps to the right of the graph are both at a set signal intensity threshold
between Z =−2 and Z = +3. *p = 0.001 unpaired two-tailed t-test.
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the dentate gyrus (DG; Figure 4C). When analyzed
as intensity ratio between CA1 and DG, there is signifi-
cantly greater differential activity in rTg4510 compared
to nonTg mice (Figure 4D). This was observed de-
spite reduced hippocampal thickness in these animals
(Figure 4E). Reduced volume was further confirmedby manual segmentation of dorsal hippocampal sub
regions. Approximately 30% of hippocampus volume
was decreased in rTg4510 compared to nonTg mice
(Figure 5A). On the other hand, enlarged microg-
lia staining was clearly visible despite significant neur-
onal loss in CA1 region in 6 month-old rTg4510 mice
(Figure 5B).
Figure 2 Functional mapping of basal neural activity in control
nonTg and mutant tau expressing rTg4510 mice using MEMRI.
A) Coronal view of dorsal hippocampal signal intensity in nonTg and
rTg4510 mice. B) Axial sections illustrating from top-to-bottom
(dorsal-to-ventral) slices the signal intensity within the dorsal and
ventral hippocampal subareas (red arrows).
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rTg4510 mice develop NFTs and show significant loss of
hippocampal neurons at around 5–6 months. Neuronal
loss may be severe (~80%) by 8 months [26]. These fac-
tors are likely to contribute to impairments observed in
spatial navigation memory previously reported using the
water maze test [27], a behavior that is associated with
neuronal activity in the dorsal hippocampus. The
present study used in vivo MEMRI to map brain activa-
tion in control and rTg4510 mice under baseline, non-
stimulated conditions. We observed significantly lower
signal intensity, which may reflect underlying reductions
in neuronal firing in rTg4510 versus control littermates.
This effect appeared selective for memory formation
structures, such as the hippocampus and amygdala, and
was not observed in other ROI such as the septum, cere-
bellum, striatum, midbrain and brainstem. The hippo-
campus and amygdala play important roles in learning
and memory, with the hippocampal structures contribut-
ing significantly to declarative memory while the amyg-
dala contributes to implicit or emotional memory
formation. While there is growing evidence that progres-
sive reductions in hippocampal activity lead to general-
ized memory impairments, the implications for the
amygdala are new for the rTg4510 mouse. The amyg-
dala, particularly the basolateral regions, develop NFT
neuropathology, however, a mechanism in rTg4510 mice
remains to be thoroughly investigated. Dickey et al.
(2009) immunohistochemically stained for tau and found
no staining in thalamus. Indirect effects of tau pathology
(or tau expression) in other regions, such as the neocor-
tex, may have contributed to the differences observed
here. In addition, we observed increases in signal inten-
sity (activity) in the striatum, an effect that might reflect
some changes in disinhibitory process arising from cor-
tical inputs. However, despite the lack of any evidence of
neuronal loss in the striatum, this region does accumu-
late NFTs beginning around 5.5 months [26].
Progression of NFT pathology in rTg4510 mice has
been considerably explored by several groups. Immuno-
histochemical analysis revealed that rTg4510 mice de-
velop pre-tangle pathology at 2.5 M and fully formed
NFTs at 4 M in the cortex and at 5.5 M in the hippo-
campus [12,28]. NFT pathology in the hippocampal for-
mation occurs in a distinctly staged sub regional pattern
beginning from CA1 to CA3 and dentate gyrus [28].
Biochemical analysis of the rTg4510 hippocampus
Figure 3 MEMRI of control nonTg and mutant tau expressing
rTg4510 mice. A) Normalize signal intensity across various ROI
(expressed as mean Z scores of voxels equal or above 1). B) Active
volume across various ROI (expressed as mean volume – in mm3 -
of voxels equal or above 1). C) Mean intensity projection images
highlighting intensity and active volume in areas of the striatum,
hippocampus and amygdala (purple, yellow-orange and light blue,
respectively). *p < 0.05 t-test comparing means of nonTg vs
rTg4510 mice.
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drastically increased from 4 months to 6 months of age
[27,29-31]. In agreement with these neuropathological
observations, our in vivo MRI analysis from rTg4510
mice (5.5-6.3 M) showed significant reduction of both
neural activity and volume in the hippocampus. We
observed significant reduction of signal intensity in the
dentate gyrus of rTg4510 mice. Because CA1 pyramidal
neurons were significantly decreased at this age, other
sub regions of the hippocampus may receive less signal-
ing associated with neural activity. Similar to our present
observations, Yang et al. (2011) showed increased react-
ive astrocytic gliosis and enlarged microglia in CA1 from
8 M male rTg4510. One interesting possibility may be
the sequestering of Mn2+ in microglial cells occurs in
rTg4510 CA1. This would either increase CA1 signal or
pull away signal from the DG. An in-depth neurochem-
ical investigation is warranted. An important follow up
will be to control the expression of transgenic tau and
the progression of NFT formation and/or neuronal loss
through the administration of doxycycline and examine
whether mice show unbalanced neural activity across
hippocampal sub regions at different stages of disease
progression.
A series of experiments using MEMRI have been carried
out to examine axonal transport rates along the olfactory
and optic tracts in transgenic mice for amyloid precursor
protein (APP) expression. Using a fast temporal series of
T1 weighted image acquisitions it was shown that there is
an age progressive decline in olfactory tract axonal trans-
port rates of Mn2+ that worsened after plaque formation.
In a subsequent study it was demonstrated that loss of
APP in knockout mice resulted in reduced axonal trans-
port rates for Mn2+, which was recovered by over-
expressing human wildtype tau [22]. Similar deficits in
axonal transport rates have been reported in regions of
the visual system and hippocampal formation of APP
knockout mice [24] and in the olfactory system of triple
transgenic mice expressing APP and human presenilin
[23]. The above references illustrate the versatility of the
MEMRI method. Localized in vivo treatment can be used
to track not only global brain activity as in the present
work, but also transport rates on selective regions of the
CNS [32]. Our present results are consistent with recent
work published by Kimura et al. (2007) showing lower ac-
tivity in hippocampal and surrounding parahippocampal
areas of aged mice with hyperphosphorylated tau protein.
Levels of signal intensity in the parahippocampal areas
highly correlated with performance on a spatial learning
task [33]. In the latter study Mn2+ was provided to animals
only 4 hours prior to imaging session and thus provides
evidence of significant brain uptake of Mn2+ across the
blood brain barrier of mice. This is supported by in vitro
studies showing rapid uptake of Mn2+ in brain, which
Figure 4 Manganese enhanced intensity and thickness of hippocampus. A) Representative coronal sections of non Tg and rtg4510 mouse
brains. The coronal slices were at the level Bregma −2 mm. Sub-regions of hippocampus were drawn as CA1 (green) and DG (purple). Arrows
showed the analyzed position of hippocampus thickness. The position was set at 1.5 mm from center. Scale bar=2 mm. B) Relative intensity of
CA1 region was normalized by averaged intensity of whole brain. C) Relative intensity of DG region was normalized by averaged intensity of
whole brain. D) Ratio of intensity between CA1 and DG. E) Comparison of hippocampus thickness between non Tg (n=5) and rTg4510 (n=5)
mice. **p<0.01, ***p<0.001.
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processes [34].
To our knowledge, this is the first MEMRI study exam-
ining neural activation in the rTg4510 mouse. Previous
work on this transgenic mouse has focused on chemical
and volumetric differences compared to controls. Both
male and female mutant tau-expressing mice show
reduced total brain volume which is largely associated
with lower cortical and hippocampal volume [25]. We
observed this feature as well and also noted the previously
reported widening of ventricles [25]. This is consistent
with postmortem tissue analysis in these same animals
[12,26]. Proton MR spectroscopy showed greater myoino-
sitol concentrations in the hippocampus and thalamus of
rTg4510 mice, and this is consistent with increased gliosis
[25]. Interestingly, N-acetylaspartate, which is often taken
as a marker of neuronal function, was not different
between controls and rTg4510 mice. We observe here
that in vivo neural activity is reduced during baselineconditions in these animals. The previously reported
lower number of neurons [26], which may lead to lower
hippocampal volume [25], also may have accounted for
the generally lower signal intensity in this region in
rTg4510 mice. However, cortical neural activity was not
different between control mice and rTg4510 mice despite
the reduced volume in the latter. This could signify that
the lower neural activity is due to reduced functional
activity in memory structures. We also found that the re-
duction in hippocampal signal intensity is not uniform
through the subanatomical layers of this paleocortical re-
gion. rTg4510 mice show a somewhat modest, but signifi-
cant increase in signal intensity in the CA1 region. It is
tempting to speculate on what such an effect may be asso-
ciated with. One possibility could be due to compensatory
changes in neuronal activity across the dorsal hippocam-
pal areas; however, this would potentially result in main-
tenance of higher levels of performance on spatial
navigation and memory tasks. Past data do not support
Figure 5 Volumes and immunohistochemical images of
hippocampus sub regions. A) Hippocampal volumes of
segmented in vivo images. Whole hippocampus, dorsal CA1 and
dorsal dentate gyrus regions (DG) were manually segmented. Ratios
between nonTg and rTg4510 were shown as percentage (%). B) Iba-
1 and CP13 antibody stainings of hippocampus (CA1) in 6 month-
old rTg4510 and nonTg littermate. Activated microgila cells detected
by Iba-1 were intensely stained in the rTg4510 hippocampus. CP13
staining in rTg4510 showed hyperphosphorylated tau accumulation
in CA1 neurons. Scale bar=200 mm.
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linked to gliosis, which would be consistent with past
work by Yang et al. (2012). Microglial cells migrating to
this region might sequester Mn2+ to such an extent that
they result in increased signal intensity. This would not be
due to increased neuronal activity, but rather it would be
in line with the pathogenicity observed with tau over-
expression at this age of the mice. This is somewhat sup-
ported by the literature. Quinolic acid lesions of neural
tissue result in greater levels of Mn2+ accumulation than
in controls, thus supporting internalization of Mn2+ in
both neurons and glial cells [35]. In conclusion, we find
that mice over expressing human mutant tau(P301L) show
lower brain activity in selected regions involved in mem-
ory formation. The present novel findings are consistent
with previous behavioral and biochemical studies in the
rTg4510 mouse. Moreover, the methods used provide a
novel approach to explore the specific relation between
genetically-driven expression of pathogenic tau and func-
tional changes over neurodegenerative disease progression.
Methods
Mice
The parental P301L tau responder line, parental tTA acti-
vator line, and the resultant F1 rTg4510 mice and litter-
mates were generated and maintained as previously
described [12]. Mice were maintained on a standard dietlacking doxycycline to ensure that transgenic tau was
expressed throughout the lifetime of the experimental ani-
mals (weights were 25-40 g at the time of imaging). All
mice were kept in standard size mouse cages (29 x 18 x
13 cm; up to 5 per same sex groups) at 20-26°C on a daily
12 hour light–dark cycle (light on during 0700 – 1900)
with ad libitum access to food and water. Mice kept under
these conditions were handled twice per week. Animals
were generated and cared for in accordance with the
guidelines published in the Guide for the Care and Use of
Laboratory Animals (8th Edition, 2011) and in adherence
to the National Institutes of Health and the American As-
sociation for Laboratory Animal Science guidelines. All
procedures involving live mice received prior approval
from the Institutional Animal Care and Use Committee of
the University of Florida.
Manganese chloride pretreatment
Manganese (II) chloride tetrahydrate was purchased from
Sigma-Aldrich Chemical Co. (St. Louis, MO, USA) and
was dissolved in ddH2O and sterile filtered prior to ad-
ministration. We first carried out pilot experiments to
examine the optimal MnCl2 dose (20 and 70 mg/kg) that
produced T1 weighted signal enhancement in the absence
of motor impairments. These experiments were carried
out on a separate cohort of animals at 5.3-6.3 months of
age (M) and resulted in selection of the 70 mg/kg MnCl2
solution. This dose produced results similar to those
reported in previous work [18]. In order to map basal
brain activity in rTg4150 mice (n=5; 5.5-6.3 M) and con-
trol nonTg littermates (n=5; 5.5-6.3 M), MnCl2 was admi-
nistered at a dose of 70 mg/kg, i.p. 24 hrs prior to MRI
scanning. Animals were handled every two weeks and
acclimatized to the investigator providing the injections.
After injections, mice were returned to their home cage
and imaged the following day.
Magnetic resonance imaging
Images of anesthetized mice were collected on an actively
shielded 4.7-Tesla Magnex Scientific MR scanner controlled
by Agilent Technologies VnmrJ 3.1 console software. A 38-
mm quadrature transmit/receive radiofrequency (RF) coil
tuned to 200 MHz was used (Insight NeuroImaging Sys-
tems, LLC, Leominster, MA). Anesthesia was initially
induced under 2.0-2.5% isoflurane (0.1 mL/min) delivered
in 100% oxygen for 30–60 seconds and levels were then
maintained between 1.0-1.25% throughout the entire setup
and imaging session. Mice were placed prone on a custom-
made plastic bed with a respiratory pad placed underneath
the abdomen. They were covered with disposable paper
towel to aid in preserving body warmth. Body temperatures
were maintained using a warm air recirculation system that
received feedback from a fiber optic thermocouple micro-
probe (SA Instruments, Inc., New York). Respiratory rates
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30 beats per minute by adjusting isoflurane levels between
1–1.25%. Incisors were secured on the front end of the
plastic bed to minimize motion. The front half of the bed
was aligned and clamped inside the quad RF coil and
placed inside the isocenter of the scanner. Images were
acquired using a T1 -weighted 3D gradient echo sequence
with the following parameters: repetition time (TR) =
35 ms, echo time (TE) = 12 ms, flip angle α = 50°, data
matrix 256 X 1282 (along read X phase X slice directions),
size 30 mm X 20 mm2 (resolution 200 X 156 μm2 along
the same read X phase X slice directions). Total scan time
per mouse was 57 minutes.
Data processing and statistical analysis
Figure 1A provides a diagram describing portions of
the image processing and data analysis procedure. Accu-
mulation of Mn2+ within brain tissue shortens its T1 re-
covery time, leading to enhanced signal intensity [15,16].
However, there is significant scan-to-scan variability that
requires normalization before carrying out between-
groups’ statistics. Various normalization procedures have
been used in the past such as normalizing to phantoms
containing chemical constituents of grey matter [36],
normalization to specific regions of interest (ROI) not
anticipated to sequester Mn2+ during specific tasks or
stimuli [32], or normalizing brain to muscle tissue near
the sampled ROI [22]. In the present study, we used a
voxel-wise Z-score normalization procedure similar to
[37] that facilitates within and between groups compari-
sons at a set threshold level and minimizes some of the
between scan variability (Figure 1B). Image processing
was carried out using itk SNAP (http://www.itksnap.
org), OsiriX (http://www.osirix-viewer.com/), and image
math scripts available on FSL (http://www.fmrib.ox.ac.
uk/fsl/). As shown in Figure 1A, a whole brain mask was
generated per each scan and used to first crop out the
non-brain portions of 3D MR scans (non-brain voxels
were set to 0). A non-linear filter was applied to the
cropped images to reduce noise without altering reso-
lution [38]. Scans were aligned with a segmented atlas of
the adult C57BL/6 J mouse brain (http://brainatlas.mbi.
ufl.edu/) using an automated affine linear registration
tool from FSL [39]. To overcome differences in brain
volume between control and rTg4510 mice [28,40],
subject-specific versions of the atlas were made based on
alignment and warping of the atlas coordinates to each
subjects’ scan space (12 parameter affine registration).
Alignment was verified for accurate delineation of ROI
and manually adjusted if needed (Figure 1A) The ana-
tomical location of ROI was compared to a histological
atlas of the mouse brain [41]. Finally, each scan
was converted to a Z score map through a voxel-wise
normalization procedure. The mean signal intensityacross the entire extracted brain volume (x ) was sub-
tracted from each voxel (xi) and then divided by the
variance (σ):
ZScore ¼ xi x
σ
A pre-set threshold of Z ≥ 1 was selected based on a
priori observation of individual datasets and a close in-
spection of their intensity distribution histograms. This
corresponds to a threshold of 1 standard deviation above
the mean. All voxels with z score values below this thresh-
old were set to zero. The intensity histograms in Figure 1B
show mean voxel counts for the entire brain of 5 rTg4510
mice and 5 control mice included in the study. Rescaling
of intensity values based on each subjects’ signal intensity
variance allowed consistent sampling of brain voxels
showing increase signal across each subject. The voxels
exceeding the threshold value of z =1 were considered in
our statistical analysis as having higher signal intensities
(exceeding 1 standard deviation above the mean signal in-
tensity across the whole brain). The segmented ROIs in
the digital atlas of the mouse brain included the neocortex,
striatum, globus pallidus, olfactory bulb, hypothalamus,
septum/basalforebrain, midbrain, brainstem, thalamus,
hippocampus, amygdala and cerebellum. Upon analyzing
all regions, the hippocampus showed major differences be-
tween rTg4510 and control mice. However, the digital
atlas does not segment sub regions of the hippocampus.
Therefore, a separate analysis was also carried out to
examine in detail the volume of the hippocampus, which
has previously been reported to be smaller in rTg4510
[28]. For this analysis, dorsal hippocampal sub regions
CA1 and DG were manually traced. Mean normalized
signal intensity values for each ROI were compared using
an unpaired two-tailed t-test (homoscedastic variances,
α ≤ 0.05).
Immunohistochemical staining
Formalin fixed brains were paraffin embedded and cut
into sagittal (5 μm) sections. Standard immunohisto-
chemical procedure was implemented with the Dako
Universal Autostainer (Dako, Carpinteria, CA). Primary
antibodies used CP13 (phosphorylated tau at Ser202,
provided by Dr. P.Davies, Albert Einstein College of
Medicine) and ionized calcium-binding adaptor mol-
ecule 1 (Iba-1, Wako Chemicals USA, Richmond, VA).
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